129 related articles for article (PubMed ID: 26073685)
1. CD1a-positive dendritic cell density predicts disease-free survival in papillary thyroid carcinoma.
Hilly O; Rath-Wolfson L; Koren R; Mizrachi A; Hamzany Y; Bachar G; Shpitzer T
Pathol Res Pract; 2015 Sep; 211(9):652-6. PubMed ID: 26073685
[TBL] [Abstract][Full Text] [Related]
2. Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation.
Pusztaszeri MP; Sadow PM; Faquin WC
Cancer Cytopathol; 2013 Apr; 121(4):206-13. PubMed ID: 23042745
[TBL] [Abstract][Full Text] [Related]
3. The role of s100-positive dendritic cells in the prognosis of papillary thyroid carcinoma.
Hilly O; Koren R; Raz R; Rath-Wolfson L; Mizrachi A; Hamzany Y; Bachar G; Shpitzer T
Am J Clin Pathol; 2013 Jan; 139(1):87-92. PubMed ID: 23270903
[TBL] [Abstract][Full Text] [Related]
4. Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.
Chowdhury S; Veyhl J; Jessa F; Polyakova O; Alenzi A; MacMillan C; Ralhan R; Walfish PG
Oncotarget; 2016 May; 7(22):32318-28. PubMed ID: 27086918
[TBL] [Abstract][Full Text] [Related]
5. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of dendritic cells in early squamous cell carcinoma of the tongue.
Hilly O; Strenov Y; Rath-Wolfson L; Hod R; Shkedy Y; Mizrachi A; Koren R; Shpitzer T
Pathol Res Pract; 2016 Dec; 212(12):1138-1143. PubMed ID: 27720281
[TBL] [Abstract][Full Text] [Related]
7. A decreased peritumoral CD1a+ cell number predicts a worse prognosis in oral squamous cell carcinoma.
Jardim JF; Gondak R; Galvis MM; Pinto CAL; Kowalski LP
Histopathology; 2018 May; 72(6):905-913. PubMed ID: 29023924
[TBL] [Abstract][Full Text] [Related]
8. Expression of MRP1 and ABCG2 is associated with adverse clinical outcomes of papillary thyroid carcinoma with a solid component.
Ohashi R; Kawahara K; Namimatsu S; Okamura R; Igarashi T; Sugitani I; Naito Z
Hum Pathol; 2017 Sep; 67():11-17. PubMed ID: 28411177
[TBL] [Abstract][Full Text] [Related]
9. Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters.
Proietti A; Ugolini C; Melillo RM; Crisman G; Elisei R; Santoro M; Minuto M; Vitti P; Miccoli P; Basolo F
Thyroid; 2011 Nov; 21(11):1209-15. PubMed ID: 22007938
[TBL] [Abstract][Full Text] [Related]
10. Survival Analysis of Papillary Thyroid Carcinoma in Relation to Stage and Recurrence Risk: A 20-Year Experience in Pakistan.
Hassan A; Razi M; Riaz S; Khalid M; Nawaz MK; Syed AA; Bashir H
Clin Nucl Med; 2016 Aug; 41(8):606-13. PubMed ID: 27124680
[TBL] [Abstract][Full Text] [Related]
11. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
Jia M; Guo Y; Lu X
Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
[TBL] [Abstract][Full Text] [Related]
12. Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma.
Goldman SA; Baker E; Weyant RJ; Clarke MR; Myers JN; Lotze MT
Arch Otolaryngol Head Neck Surg; 1998 Jun; 124(6):641-6. PubMed ID: 9639473
[TBL] [Abstract][Full Text] [Related]
13. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
14. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer.
Nunes LM; Ayres FM; Francescantonio IC; Saddi VA; Avelino MA; Alencar Rde C; Silva RC; Meneghini AJ; Wastowski IJ
Hum Immunol; 2013 Apr; 74(4):447-51. PubMed ID: 23261411
[TBL] [Abstract][Full Text] [Related]
15. Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma.
Sung TY; Kim M; Kim TY; Kim WG; Park Y; Song DE; Park SY; Kwon H; Choi YM; Jang EK; Jeon MJ; Shong YK; Hong SJ; Kim WB
Thyroid; 2015 Sep; 25(9):1020-5. PubMed ID: 26148673
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of a solid component in papillary thyroid carcinoma.
Ohashi R; Kawahara K; Namimatsu S; Igarashi T; Sakatani T; Sugitani I; Naito Z
Histopathology; 2017 Apr; 70(5):775-781. PubMed ID: 27882585
[TBL] [Abstract][Full Text] [Related]
17. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
[TBL] [Abstract][Full Text] [Related]
18. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
[TBL] [Abstract][Full Text] [Related]
19. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
[TBL] [Abstract][Full Text] [Related]
20. Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells.
Scarpino S; Stoppacciaro A; Ballerini F; Marchesi M; Prat M; Stella MC; Sozzani S; Allavena P; Mantovani A; Ruco LP
Am J Pathol; 2000 Mar; 156(3):831-7. PubMed ID: 10702399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
